Open-label randomized study of individualized pharmacokinetically (PK)-guided dosing versus body surface area (BSA) dosing of paclitaxel (PTX) in advanced Non-Small Cell Lung Cancer (NSCLC)

Open-label randomized study of individualized pharmacokinetically (PK)-guided dosing versus body surface area (BSA) dosing of paclitaxel (PTX) in advanced Non-Small Cell Lung Cancer (NSCLC) Ann [...]

Paclitaxel Pharmacokinetics And Response To Chemotherapy

Paclitaxel Pharmacokinetics And Response To Chemotherapy In Patients With Advanced Cancer Treated With A Weekly Regimen This studied followed others in observing that paclitaxel pharmacokinetics [...]

Population Pharmacokinetics And Pharmacodynamics Of Paclitaxel And Carboplatin

Population Pharmacokinetics And Pharmacodynamics Of Paclitaxel And Carboplatin In Ovarian Cancer Patients: A Study By The European Organization For Research And Treatment Of Cancer-Pharmacology [...]

Paclitaxel Combined With Carboplatin In Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

Open-Label, Randomized Study Of Individualized, Pharmacokinetically (PK)-Guided Dosing Of Paclitaxel Combined With Carboplatin In Advanced Non-Small Cell Lung Cancer (NSCLC) Patients. This study [...]